NOS1 and Huntington disease: The finding that hippocampal cGMP levels are decreased in R6 mice, and in human HD hippocampus, together with previous results indicating that nNOS pathway is also highly affected in the striatum and cortex of HD mice [11–15], suggests that PDE5 inhibition can be a good therapeutic strategy for cognitive improvement in HD.